Today: 21 May 2026
Browse Category

NYSE:MMC 16 October 2025 - 11 February 2026

Marsh stock price (MRSH) dips as bond-sale filing lands and AI fears linger

Marsh stock price (MRSH) dips as bond-sale filing lands and AI fears linger

Marsh & McLennan shares fell 0.71% to $174.09 by 2:39 p.m. EST Wednesday, following sector declines triggered by AI-driven insurance tools. The company filed for a new senior notes offering, with details pending, and registered up to 9 million shares for its stock award plan. Trading volume reached about 3 million shares. Marsh trades on the NYSE under ticker MRSH.
11 February 2026
··
Marsh CEO Slams Rivals’ “Unlawful” Hiring Blitz as Shares Slide

Marsh CEO Slams Rivals’ “Unlawful” Hiring Blitz as Shares Slide

Marsh & McLennan CEO John Doyle accused rivals of “unlawful and unethical” talent raids during the Oct. 16 earnings call, citing breaches of non-compete covenants. Marsh has sued competitors including Alliant and Howden over alleged poaching. Q3 revenue rose 11% to $6.4 billion, but shares dropped about 8%. Marsh will rebrand as “Marsh” in 2026 and launch a new Business & Client Services unit.
19 October 2025
·

Stock Market Today

  • Teradyne, Kulicke and Soffa, Impinj, Microchip, IPG Photonics Stocks Slide on U.S.-China Semiconductor Summit Outcome
    May 21, 2026, 2:58 AM EDT. Shares of Teradyne, Kulicke and Soffa, Impinj, Microchip Technology, and IPG Photonics dropped sharply following the U.S.-China summit, which ended without key breakthroughs on semiconductor exports. Expectations for U.S. approval of Nvidia's H200 chip shipments to China were unmet, disappointing investors. U.S. Trade Representative Jamieson Greer indicated semiconductors were not a negotiation focus, dampening near-term optimism. Despite the sell-off, IPG Photonics' stock, known for volatility, remains down significantly from its 52-week high but has gained 34.3% year-to-date. Market reactions highlight cautious sentiment amid geopolitical tensions, with analysts skeptical about swift comprehensive deals due to national security concerns.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop